Advertisement
Use of GLP-1s and improving cardiovascular health lowers risk of hematologic malignancies
Consider each patient's unique disease progression and treatment goals when choosing a strategy
New papers review the data and provide guidance on antiobesity medications and other options
Patient loses 148 pounds in 18 months, reduces BMI to 26
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Findings show greater reduction in CKD progression, kidney failure than GLP-1RAs
A weight-management program plus anti-obesity medication performs well
Cleveland Clinic study finds that durable weight loss is key to health benefits
Comprehensive approach can make a transformative impact
More report a clinically meaningful change in function at 90 days compared to patients with lower BMI
Positive emotions, low impulsivity appear to safeguard against weight gain, other comorbidities
Advertisement
Advertisement